Affordable Access

deepdyve-link
Publisher Website

Preoperative heart failure in the Medicare population undergoing mitral valve repair and replacement: An opportunity for improvement

Authors
  • Vassileva, Christina M.
  • Ghazanfari, Naseem
  • Markwell, Stephen
  • Boley, Theresa
  • Hazelrigg, Stephen1, 2, 3, 2
  • 1 Department of Surgery
  • 2 Southern Illinois University School of Medicine
  • 3 Department of Internal Medicine
Type
Published Article
Journal
Journal of Thoracic and Cardiovascular Surgery
Publisher
American Association for Thoracic Surgery
Publication Date
Jan 01, 2014
Accepted Date
Dec 05, 2013
Identifiers
DOI: 10.1016/j.jtcvs.2013.12.010
Source
Elsevier
Keywords
License
Unknown

Abstract

BackgroundElderly patients are under-represented in most surgical series of mitral valve surgery. The impact of preoperative heart failure (HF) on the outcomes of this subset has not been extensively studied. Methods and resultsThe study included 45,082 Medicare beneficiaries who underwent primary isolated mitral valve repair (MVP) (n = 16,850) or replacement (MVR) (n = 28,232) from 2000 to 2009. Medicare claims from the year before and the year of the index hospitalization were reviewed for documentation of HF to examine the operative mortality and long-term survival of patients with and without preoperative HF. Preoperative HF was present in 52.5% and 64.8% of patients who underwent repair and replacement, respectively. Duration of HF greater than 3 months was present in a significant proportion of patients (18.2% for MVP and 22.7% for MVR). Adjusted operative mortality was higher for patients with preoperative HF (MVP odds ratio [OR], 1.46; 95% confidence interval [CI], 1.21-1.78; MVR OR, 1.36; 95% CI, 1.23-1.51). Patients without preoperative HF had better long-term survival (MVP hazard ratio [HR], 2.23 [95% CI, 2.09-2.36]; MVR HR, 1.80 [95% CI, 1.73-1.86]). After adjustment, a preoperative HF diagnosis was still associated with 52% and 36% increased risk of death over the 10-year follow-up period for patients who underwent MVP and MVR, respectively. Preoperative HF duration greater than 3 months conferred an excess 28% higher risk of death on long-term follow-up compared with patients with HF less than 3 months. ConclusionsPreoperative HF is present in a large number of elderly patients undergoing primary isolated mitral valve surgery and adversely affects their short-term and long-term survival, irrespective of procedure type (repair or replacement). The study supports the early identification of elderly patients with mitral valve disease and referral to surgery before the onset of HF.

Report this publication

Statistics

Seen <100 times